High Precision 8 Lance Electronic Pill Tablet Soft Gelatin Capsule Filling Counting Machine for Pharmaceutical Industry

Name: High Precision 8 Lance Electronic Pill Tablet Soft Gelatin Capsule Filling Counting Machine for Pharmaceutical Industry
Brand: Jining Factop International Trade Co., Ltd.
SKU: 1972072671

Shandong, ChinaJining Factop International Trade Co., Ltd.

US$1,200.00

1-4 Sets

US$1,100.00

5+ Sets

Product profile

Customization

Available

Application

Chemical Industry, Clinical Diagnosis, Cosmetic Industry, Food Industry, Pharmaceutical Industry

Automation Grade

Automatic

Model NO.

SL-8

Features

Production Line

Machine Material

Stainless Steel

Packaging Material

Plastic, Bottle

Warranty

2 Year

Transport Package

Wooden

Specification

350kg

Trademark

Origin

China

HS Code

8422400090

Production Capacity

500 Set/Week

Key features

High Precision Counting: Accuracy exceeds 99.8% with photoelectric sensor technology.

Anti-High Dust Technology: Stable operation in high dust environments using advanced sensing.

Wide Compatibility: Handles tablets, capsules, softgels, and particles from 3-22mm.

GMP Compliant Design: Fully compliant with GMP requirements for pharmaceutical use.

Intelligent Control System: Features auto-detection, alarms, and self-check functions.

Vibration Feeding Mechanism: Ensures uniform feeding without damaging drugs or capsules.

2-Year Warranty Coverage: Comprehensive warranty for all mechanical equipment.

Easy Maintenance: Simple disassembly, cleaning, and component replacement.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryMinor Customization

Jining Factop International Trade Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2014-06-20Nearest Port: Shanghai, NingboAverage Response Time: ≤0.80hTerms of Payment: T/T, Western Union, Money GramInternational Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP, DAP, FCA

AI-Powered supplier vetting

SummaryThe supplier manufactures pharmaceutical and packaging machinery, including blister packing, sugar coating, tablet counting, and related production equipment. Its products are exported to the United States, Europe, the Middle East, Southeast Asia, and North America, with exports representing 51%–70% of total sales and eight years of exporting experience. Production and delivery indicators are partially positive, including peak- and off-season lead times within 15 workdays and stated quality assurance with raw-material traceability. However, the supplier has no documented corrective-action or complaint-handling procedures, no supplier-service assessment records, no listed management-system certification, no overseas service infrastructure, no inventory service capability, and no new products launched during the previous year. R&D and design resources appear limited, with one R&D engineer and minor customization capability. Customer retention is reported at 50%–80%, but specific customer cases are not provided.

Supplier typeThe supplier is a manufacturer and developer of pharmaceutical production and packaging machinery, including blister packing, sugar coating, tablet counting, and powder-to-tablet/capsule equipment. It sells domestically and exports to the United States, Europe, the Middle East, Southeast Asia, and North America, with eight years of export experience and stated self-operated import/export rights.

CertificationsThe supplier states that its tablet-press digital control system supports alignment with cGMP and FDA requirements, but the available information does not identify a certification held by the supplier. Supplier management-system certification is explicitly listed as NIL, so no formal certification holding is evidenced.

After-Sales capabilityThe supplier cites good after-sales service as a company tenet and accepts multiple quotation terms, but it has no written corrective/preventive-action procedures, no written customer-complaint procedures or records, and no written service-capability assessment procedure. It also reports no overseas agents or branches, overseas warehouse, showroom, inventory capability, or overseas service countries, indicating limited documented and local service infrastructure.

R&D capabilityThe supplier reports integrated development and production capabilities and describes high-tech machinery development, but it has only one R&D engineer, one year of total R&D-engineer experience is reported, and no new products were launched during the previous year. These explicit indicators show limited recent innovation output.

Production capacityThe supplier reports integrated manufacturing of several pharmaceutical machinery categories, exports representing 51%–70% of sales, annual production output above the stated threshold, and lead times within 15 workdays in both peak and off-season periods. Quality assurance and raw-material traceability are reported, although finished products are randomly inspected and checked by packing staff, which limits the evidence of a robust final-inspection system.

Customization capabilityThe supplier explicitly offers minor customization. No evidence is provided of moderate or extensive engineering customization, so the demonstrated capability is limited to minor modifications.